Pacific Biosciences of Califor - PACB - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Pacific Biosciences of Califor - SIC # 3845

Ticker	Exchange	SIC #	Website	Latest Ticker
PACB	Nasdaq	3845	http://www.pacificbiosciences.com.	2.45 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Pacific Biosciences of Califor PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of - May 22nd, 2013 7:38 am Insiders And Funds Are Bullish On These 3 Small Cap Healthcare Stocks - May 21st, 2013 10:57 am PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Financials - May 17th, 2013 11:04 am Pacific Biosciences and Sage Science Announce Co-Marketing Partnership - May 16th, 2013 5:30 am PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 10-Q, Quarterly Report - May 10th, 2013 8:13 am New Assembly Method Published for Rapid and Automated Genome Sequencing Using Long-Read, Single Molecule, Real-Time (SMRT(R)) Sequencing - May 6th, 2013 5:30 am Is Illumina's Stock Destined for Greatness? - Apr 30th, 2013 12:07 pm 5 Stocks Burning Their Shorts - Apr 30th, 2013 7:04 am 3 Biotechs Flying Under The Radar - Apr 30th, 2013 5:01 am Pacific Biosciences of California Management Discusses Q1 2013 Results - Earnings Call Transcript - Apr 23rd, 2013 5:40 pm Pacific Biosciences of California Earnings: Here’s Why Investors are Excited Now - Apr 23rd, 2013 4:10 pm Pacific Biosciences of California, Inc. Announces First Quarter 2013 Financial Results - Apr 23rd, 2013 2:55 pm Pacific Biosciences of California, Inc. Announces First Quarter 2013 Financial Results - Apr 23rd, 2013 2:00 pm Four Lessons From IBM And Roche's Failed DNA Collaboration - Apr 23rd, 2013 9:46 am Illumina Flexes Its Muscles A Bit - Apr 23rd, 2013 8:57 am PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial - Apr 23rd, 2013 7:10 am Q1 2013 Pacific Biosciences Of California Inc Earnings Release - After Market Close - Apr 23rd, 2013 5:07 am Illumina: Thermo Fisher-Life Deal Unlikely To Threaten Its Market-Leading Position - Apr 17th, 2013 8:54 am Pacific Biosciences of California, Inc. First Quarter 2013 Financial Results Call - Apr 16th, 2013 4:08 pm Pacific Biosciences of California, Inc. First Quarter 2013 Financial Results Call - Apr 16th, 2013 2:15 pm View All Current Headlines >>